newsfilter
← Latest News
GlobeNewswire·

Y-mAbs to Participate in Upcoming Investor Conferences in October

NEW YORK, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel